NCT07219017View on ClinicalTrials.gov

A Study to Assess the Mass Balance of Oral ABBV-1354 in Healthy Adult Male Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Healthy Volunteer

Interventions

DRUG

ABBV-1354

Oral solution

Trial Locations (1)

53704

RECRUITING

Fortrea Clinical Research Unit Inc, Madison

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AbbVie

INDUSTRY